Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.

@article{Fehm2009BisphosphonateinducedOO,
  title={Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.},
  author={Tanja N. Fehm and Vance P. Beck and Malgorzata J. Banys and Hans Peter Lipp and Martin Hairass and Siegmar Reinert and Erich Franz Solomayer and Diethelm Wallwiener and Michael Krimmel},
  journal={Gynecologic oncology},
  year={2009},
  volume={112 3},
  pages={605-9}
}
OBJECTIVE Since 2003, multiple cases of bisphosphonate-induced osteonecrosis of the jaw (ONJ) were reported. The aim of this study was to describe the incidence and risk factors of ONJ in patients with breast cancer or gynecological malignancies receiving bisphosphonates (BP). METHODS ONJ was recorded for all patients with breast cancer or gynecological malignancies treated with intravenous bisphosphonates at the Department of Gynecology and Obstetrics, University Hospital Tuebingen during… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study

European Archives of Oto-Rhino-Laryngology • 2011
View 8 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…